These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2236608)

  • 1. [Development of new immunosuppressant and experimental cardiac transplantation].
    Ochiai T
    Tanpakushitsu Kakusan Koso; 1990 Jul; 35(10):1961-8. PubMed ID: 2236608
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on FK506 in experimental organ transplantation.
    Ochiai T; Sakamoto K; Nagata M; Nakajima K; Goto T; Hori S; Kenmochi T; Nakagori T; Asano T; Isono K
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):209-14. PubMed ID: 2450414
    [No Abstract]   [Full Text] [Related]  

  • 3. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of didemnin B in suppressing allograft rejection in mice and rats.
    Yuh DD; Zurcher RP; Carmichael PG; Morris RE
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1141-3. PubMed ID: 2650081
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive effects of leflunomide in a cardiac allograft model.
    Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac allograft pathology in Rhesus monkeys.
    Hollander CF
    Am J Phys Anthropol; 1973 Mar; 38(2):431-3. PubMed ID: 4632089
    [No Abstract]   [Full Text] [Related]  

  • 7. The anticoagulant effect of antithrombin III on hyperacute xenograft rejection.
    Takeshita K; Arakawa K; Okamoto M; Akioka K; Fujiwara I; Kobayashi K; Imanishi J; Oka T
    Transplant Proc; 1996 Apr; 28(2):631-2. PubMed ID: 8623314
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720.
    Suzuki S; Enosawa S; Kakefuda T; Amemiya H; Hoshino Y; Chiba K
    Transplant Proc; 1996 Jun; 28(3):1375-6. PubMed ID: 8658701
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
    Xiao F; Chong A; Foster P; Sankary H; McChesney L; Williams JM; Frieders D; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of a new immunosuppressant, CAM, on small bowel transplantation in rats.
    Sawada H; Kaihara S; Egawa H; Inomata Y; Tanaka K; Yamaoka Y
    Transplant Proc; 1996 Oct; 28(5):2512-3. PubMed ID: 8907928
    [No Abstract]   [Full Text] [Related]  

  • 11. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
    J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
    [No Abstract]   [Full Text] [Related]  

  • 14. Early experience with cyclosporine: a historic perspective.
    Kostakis A
    Transplant Proc; 2004 Mar; 36(2 Suppl):22S-24S. PubMed ID: 15041302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat heart allograft survival after treatment with verapamil, captopril, and enalapril.
    Mjörnstedt L; Lukes D; Arvidsson N; Herlitz H; Olausson M
    Transplant Proc; 1995 Dec; 27(6):3544. PubMed ID: 8540093
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of interferon alpha/beta on cardiac allografts.
    Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M
    Transplant Proc; 1996 Jun; 28(3):1250-1. PubMed ID: 8658645
    [No Abstract]   [Full Text] [Related]  

  • 17. Xanthines: ideal immunosuppressants for combination with cyclosporine?
    Lin Y; Segers C; Mikhalsky D; Schönharting M; Waer M
    Transplant Proc; 1996 Dec; 28(6):3102. PubMed ID: 8962202
    [No Abstract]   [Full Text] [Related]  

  • 18. Initial experience with FK 506 as an immunosuppressant for nonhuman primate recipients of cardiac allografts.
    Flavin T; Ivens K; Wang J; Gutierrez J; Hoyt EG; Billingham M; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):531-2. PubMed ID: 1703701
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
    Lin Y; Sobis H; Vandeputte M; Waer M
    Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012
    [No Abstract]   [Full Text] [Related]  

  • 20. Additive immunosuppressive effect of hydroxycamptothecin and cyclosporine on rejection of heart transplantation in rats.
    Shi B; Cai M; Qian Y; Zhou W; Mo C; Wang Y
    Transplant Proc; 2007 Dec; 39(10):3429-31. PubMed ID: 18089398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.